P85.03 PD-L1 Expression and Efficacy of Immunotherapy in Japanese Patients with NSCLC Harboring MET Exon 14 Skipping Mutation.

Autor: Kato, Y., Watanabe, Y., Yamane, Y., Mizutani, H., Kurimoto, F., Yamamoto, G., Akagi, K., Sakai, H.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S669-S669
Databáze: ScienceDirect